|
The Intersection Of Biotechnology And Pharmacogenomics: Health Policy Implications
Kathryn A. Phillips
Increasing knowledge of the genetic basis of disease is changing the landscape of health care. Two critical aspects are growth in biotechnology and growth in personalized health care, particularly targeting medicines based on genetic information (pharmacogenomics). This paper provides an overview of the health policy implications of the integration of biotechnology and pharmacogenomics. I examine four factors that determine whether relevant technologies will be successfully adopted, using case studies for illustration. Key policy challenges include determining the appropriate role of policy in (1) providing incentives to develop socially beneficial interventions and (2) facilitating development of the evidence base.

What's this?
This article has been cited by other articles:

|
 |

|
 |
 
V. L. Ellingrod and J. Moline
Incorporating Pharmacogenomics into Practice
Journal of Pharmacy Practice,
June 1, 2007;
20(3):
277 - 282.
[Abstract]
[PDF]
|
 |
|
Comments:
Read all Comments
- Potential Benefits of Pharmacogenomics Technologies
- Christine C. Huttin, et al.
- Health Affairs, 12 Mar 2007
[Full text]
|